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ThemechanismbywhichHFE participates in the regulation of iron homeostasis has remained enigmatic. Gao
et al. (2009) make the key discovery that the regulation of hepcidin in response to holotransferrin requires the
interaction between HFE and transferrin receptor 2 (TfR2).Among the most important breakthroughs
in understanding the regulation of iron
metabolism has been the discovery of the
peptide hormone hepcidin (Ganz, 2008).
This ‘‘master’’ iron regulatory hormone is
the primary determinant of dietary iron
absorption and body iron distribution.
Hepcidin ismade primarily by hepatocytes
and secreted into the circulation, where it
serves to downregulate iron export by
certain cell populations, including splenic
reticuloendothelial macrophages (the
primary site of body iron turnover) and
duodenal enterocytes (the primary site of
body iron absorption). Hepcidin downre-
gulates iron export by binding with and
causing the internalization and degrada-
tion of the cellular iron exporter ferroportin.
The consequent increase in splenic iron
stores anddecrease indietary ironabsorp-
tion lead to decreased circulating iron
levels. Expectedly, a feedback relationship
existsbetweenbody ironstatusandhepci-
din expression; hepcidin is upregulated in
response to iron loading and decreased
in response to iron deficiency. Character-
izing the mechanism by which iron regu-
lates hepcidin expression has proven
particularly difficult, due in no small part
to the failure of cell culture systems to
model the effects of iron observed in vivo.
A number of the molecular participants in
hepcidin regulation have been identified
by the characterization of the conse-
quences of their mutation in humans or
mice. These include molecules needed
for the normal upregulation of hepcidin in
response to iron loading (HFE, transferrin
receptor 2, hemojuvelin, SMAD4) and for
downregulation in response to iron defi-
ciency (matriptase 2) (Folgueras et al.,
2008). As a result of work attempting to
define in cell culture the molecular playersnecessary to recapitulate iron regulation
observed in vivo, Gao et al. in this issue
(Gao et al., 2009) made the key discovery
that the regulation of hepcidin in response
to holotransferrin requires the interaction
between HFE and transferrin receptor 2
(TfR2).
The role of HFE in iron metabolism has
been well studied, but not well under-
stood. It is an MHC class I molecule with-
out iron transport properties (Figure 1). As
such, much of the focus of investigation
has been on the interaction of HFE with
other molecules with iron transport prop-
erties. Initial attention was directed to-
ward transferrin receptor 1 (TfR1). Crys-
tallographic studies demonstrate that
the interaction between TfR1 and HFE
involves the a1 and a2 domains of HFE
and the transferrin-binding domain of
TfR1. Experiments with mice having
an engineered TfR1 mutation that inter-
feres with HFE binding suggest that the
TfR1-HFE interaction may serve to
‘‘sequester’’ HFE away from participation
in a hepcidin upregulatory pathway
(Schmidt et al., 2008). The discovery that
HFE can also interact with TfR2 led to
the proposal that an HFE-TfR2 complex
may be involved in this hepcidin upregula-
tion. Deletion and domain substitution
studies have demonstrated that the
HFE domains responsible for HFE-TfR2
interaction are entirely distinct from
those involved in HFE-TfR1 interactions
(Figure 1). Surprisingly, the TfR2 domain
involved in this interaction appears to be
likewise distinct from the homologous
domain on TfR1 (and, as such, is not in
competition with holotransferrin). These
observations were put together to
generate a model in which the interaction
of holotransferrin with TfR1 frees HFE toCell Metabolisinteract with TfR2, and facilitates signal
transduction to hepcidin. It had yet to
be experimentally shown, however, that
TfR2 is directly involved in signal trans-
duction between holotransferrin and
hepcidin. Gao et al. in this manuscript
demonstrate not only that TfR2 partici-
pates in this signal transduction, but also
that it requires interaction with HFE.
Several observations have supported
a role for TfR2 as the hepatocellular ‘‘iron
sensor’’ and for holotransferrin as the
circulating ligand indicator of body iron
status. Functional loss of TfR2 in humans,
mice, and zebrafish results in abnormally
low hepcidin expression and hemochro-
matosis. Genetic deficiencies in trans-
ferrin have likewise been shown in these
same species to be associated with
abnormally low hepcidin. Among the
molecules known to participate in hepci-
din regulation, only transferrin has been
shown to directly interact with iron. While
several lines of evidence lend support to
these proposed roles, the effect of holo-
transferrin on hepcidin expression in cell
culture systems has beenweak or absent.
These observations had led investigators
to conjecture that an additional cell type
is needed, or that one or more of the
essential molecular players is missing.
Gao et al. investigated the latter possibility
and found that a hepatocellular line (WIF-
B) capable of signal transduction between
holotransferrin and hepcidin had substan-
tial HFE expression, while HepG2 cells
had very little. They went on to show that
the regulation of hepcidin by holotransfer-
rin requires both HFE and TfR2 in HepG2
cells and primary hepatocytes. Finally,
they used a series of HFE chimeras to
demonstrate that the interaction between
HFE and TfR2 (but not TfR1) wasm 9, March 4, 2009 ª2009 Elsevier Inc. 211
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HFE-TfR2 interaction depends upon the
a3 domain of HFE, and the signal trans-
duction depends additionally on the cyto-
plasmic domain of HFE (Figure 1).
These data strongly support a model in
which HFE-TfR2 transduces a signal
between holotransferrin and hepcidin
expression. It would be informative to
determine if there is a dose-response
relationship between holotransferrin and
hepcidin expression, as expected if this
mechanism is responsible for the physio-
logic feedback regulation of hepcidin. It
would be also be useful to know what
effect overexpression of HFE had on
measurements of iron status and the labile
iron pool in the HepG2 cells. The overex-
pression of HFE has been shown to influ-
ence cellular iron status in cell lines that
express neither TFR1 nor TfR2 (Carlson
et al., 2004). Finally, it is not clear that the
observations made in cell culture will
directly translate to the situation in vivo.
Some observations suggest that the
absence of HFE does not completely
abolish regulation of hepcidin by iron
in vivo. For example, changes in dietary
iron in at least certain HFE knockout
mouse strains are associated with
changes in hepcidin expression (Gehrke
et al., 2005), albeit at an attenuated level.
Also, zebrafish regulate iron metabolism
by a mechanism dependent upon trans-
ferrin and on TfR2 (Fraenkel et al., 2008),
yet have no identified HFE ortholog.
It is likely that hepatocellular iron
sensing will found to be a group effort
Figure 1. Schematic Representation of the HFE Protein
Colors designate HFE domains encoded by individual exons (cyto, cyotoplasmic; tm, transmembrane).
HFE requires interaction with b2-microglobulin (b2M) for normal cell surface localization. While transferrin
receptor 1 (TfR1) interacts with the HFE a1 and a2 domains, TfR2 interacts with the HFE a3 domain. Regu-
lation of hepcidin by holotransferrin requires HFE sequences in the a3 (and cytoplasmic) domains and
interaction with transferrin receptor 2.212 Cell Metabolism 9, March 4, 2009 ª2009 Elsevier Inc.rather than a simple partnership. Recent
studies have clearly placed hemojuvelin
and matriptase 2 in a common pathway
that regulates hepcidin by modulating
signal transduction through bone
morphogenetic proteins and SMAD4
(Silvestri et al., 2008). Several lines of
evidence suggest that this pathway
contributes to the regulation of hepcidin
by iron (Lin et al., 2007; Yu et al., 2008).
The exciting results reported here by
Gao et al. provide an important step in
investigating a possible relationship
between HFE-TfR2 and this signal trans-
duction pathway.
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